Integrated BioPharma (INBP) Short Interest Ratio & Short Volume

Short interest is the volume of Integrated BioPharma shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 700 shares of INBP short. Learn More on Integrated BioPharma's current short interest.

Integrated BioPharma saw a increase in short interest in September. As of September 15th, there was short interest totaling 700 shares, an increase of 600.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Integrated BioPharma: IntelGenx Technologies Corp. (0.00%), Acurx Pharmaceuticals, Inc. (3.46%), Clene Inc. (3.89%), Equillium, Inc. (0.88%), Tempest Therapeutics, Inc. (9.06%), Gain Therapeutics, Inc. (2.39%), ImmuCell Co. (0.18%), Daré Bioscience, Inc. (0.42%), VYNE Therapeutics Inc. (0.26%), MiNK Therapeutics, Inc. (0.62%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($6.15 billion), Charter Communications, Inc. ($4.04 billion), Paychex, Inc. ($2.77 billion), Nu Holdings Ltd. ($2.71 billion), Cencora, Inc. ($2.34 billion), Aptiv PLC ($2.18 billion), Tractor Supply ($2.07 billion), International Paper ($2.01 billion), AppLovin Co. ($1.95 billion), and Moderna, Inc. ($1.89 billion). View all of the most shorted stocks.

Short selling INBP is an investing strategy that aims to generate trading profit from Integrated BioPharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Integrated BioPharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INBP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INBP, twice per month. The most recent reporting period available is September, 15 2024.